Rise of antibody-based treatments in myeloma
Sagar Lonial, MD, FACP, Winship Cancer Institute of Emory University, Atlanta, GA, explores the rise of antibody-based treatment in multiple…
Related Articles
EBMT 2024 | VJHemOnc
The 50th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) will be held in Glasgow, Scotland, and online, on 14-17 April,…
VJHemOnc – The video journal of hematological oncology
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
MDS Sessions: TP53 mutation in MDS | VJHemOnc
Welcome to The MDS Sessions brought to you by the Video Journal of Hematology and Hematological Oncology (VJHemOnc). This exclusive discussion features leading experts Amer…
VJHemOnc – The video journal of hematological oncology
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
Understanding the concept of MGRS
Nelson Leung, MD, Mayo Clinic, Rochester, MN, discusses monoclonal gammopathy of renal significance (MGRS), a classification of B-cell or plasma-cell clonal disorders that results in…
Case Study: AML diagnosis, classification, risk-stratification and treatment
Sanam Loghavi and Naval Daver discuss the current approach to the diagnosis and classification, risk-stratification and treatment options for newly diagnosed AML in the context…
VJHemOnc – The video journal of hematological oncology
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
Acquired mutations associated with resistance to BTKi in patients with CLL
Stephan Stilgenbauer, MD, University of Ulm, Ulm, Germany, discusses acquired mutations that underlie resistance to BTK inhibitors (BTKi) in patients with chronic lymphocytic leukemia (CLL).…
FDA approves cilta-cel for adult patients with R/R multiple myeloma after at least one prior line of therapy
On April 5th, 2024, the U.S. Food and Drug Administration (FDA) granted approval to ciltacabtagene autoleucel (cilta-cel), a B-cell maturation…
VJHemOnc – The video journal of hematological oncology
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…